₹541.55
▲ +5.79 +1.08%
17 Jul 2026
NSE Listed
Rossari Biotech Limited (ROSSARI)
Volume: 92,147Avg Vol 1W: 76,605.6Avg Vol 1M: 76,16952W Range:₹375₹766
Key Ratios
Checked 20h agoMarket Cap₹2,968 Cr
Current Price₹541.55
Previous Close₹535.76
High / Low (52w)₹766 / ₹375
Volume92,147
Avg Vol (1W)76,605.6
Avg Vol (1M)76,169
Stock P/E64.55
Book Value₹240.68
Dividend Yield0.1%
ROE11.2%
ROA6.5%
Revenue (TTM)₹2,419 Cr
Revenue Growth13.6%
Profit Margin6.2%
Total Debt₹100 Cr
Shares Outstanding6 Cr
Face Value₹2
EPS (TTM)₹8.3
P/B2.23
Debt / Equity0.33
50 DMA₹524.07
200 DMA₹542.13
Day change+1.08%
Price Chart
₹541.55▼ 26.35% · 1Y
2025-07-162026-07-15
20-day avg volume: 76K shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 14% YoY.
- Stock trades at a high P/E of 65.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹490 Cr | ₹498 Cr | ₹513 Cr | ₹580 Cr | ₹544 Cr | ₹586 Cr | ₹582 Cr | ₹685 Cr |
| EBITDA | ₹50 Cr | ₹52 Cr | ₹47 Cr | ₹53 Cr | ₹51 Cr | ₹55 Cr | ₹50 Cr | ₹73 Cr |
| Net Profit | ₹35 Cr | ₹35 Cr | ₹32 Cr | ₹34 Cr | ₹34 Cr | ₹37 Cr | ₹33 Cr | ₹46 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹517 Cr | ₹604 Cr | ₹718 Cr | ₹1,495 Cr | ₹1,661 Cr | ₹1,838 Cr | ₹2,084 Cr | ₹2,419 Cr |
| EBITDA | ₹66 Cr | ₹92 Cr | ₹109 Cr | ₹147 Cr | ₹166 Cr | ₹197 Cr | ₹202 Cr | ₹229 Cr |
| Net Profit | ₹46 Cr | ₹65 Cr | ₹80 Cr | ₹98 Cr | ₹107 Cr | ₹131 Cr | ₹136 Cr | ₹149 Cr |
| EPS | 9.44 | 13.23 | 15.47 | 17.7 | 19.38 | 23.62 | 24.63 | 26.93 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹250 Cr | ₹472 Cr | ₹561 Cr | ₹1,257 Cr | ₹1,368 Cr | ₹1,572 Cr | ₹1,896 Cr | ₹2,289 Cr |
| Total Liabilities | ₹126 Cr | ₹185 Cr | ₹153 Cr | ₹452 Cr | ₹452 Cr | ₹524 Cr | ₹711 Cr | ₹955 Cr |
| Equity | ₹124 Cr | ₹287 Cr | ₹409 Cr | ₹805 Cr | ₹915 Cr | ₹1,048 Cr | ₹1,185 Cr | ₹1,333 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹92 Cr | ₹77 Cr | ₹79 Cr | ₹79 Cr | ₹199 Cr | ₹97 Cr | ₹197 Cr | ₹134 Cr |
| Investing | ₹-36 Cr | ₹-190 Cr | ₹-37 Cr | ₹-299 Cr | ₹-181 Cr | ₹-103 Cr | ₹-184 Cr | ₹-219 Cr |
| Financing | ₹-29 Cr | ₹157 Cr | ₹-25 Cr | ₹292 Cr | ₹61 Cr | ₹16 Cr | ₹65 Cr | ₹186 Cr |
| Free Cash Flow | ₹92 Cr | ₹77 Cr | ₹79 Cr | ₹79 Cr | ₹199 Cr | ₹97 Cr | ₹197 Cr | ₹134 Cr |
Shareholding
Promoter 68.15% Institutions 20.38% Public 11.46%
Efficiency & Working Capital
ROCE13.1%
Interest Coverage8.1
Dividend Payout—
Debtor Days85 d
Inventory Days62 d
Payable Days49 d
Cash Conversion Cycle97 d
Working Capital Days147 d
Shareholding Details
As of 2026-03-31
Promoter68.2%
FII2.2%
DII18.2%
Institutions20.4%
Public11.5%
Promoter Pledge0%
No. of Shareholders86,972
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.4% | 68.3% | 68.3% | 68.3% | 68.3% | 68.3% | 68.2% | 68.2% | 68.2% | 68.2% | 68.2% | 68.2% |
| FIIs | 6.1% | 5.7% | 4.1% | 4% | 3.8% | 3.7% | 3.7% | 4% | 3.5% | 2.7% | 2.3% | 2.2% |
| DIIs | 17.7% | 17.7% | 18% | 17.7% | 16.9% | 17.3% | 17.5% | 17.6% | 17.8% | 18.2% | 18.3% | 18.2% |
| Public | 7.7% | 8.2% | 9.5% | 9.9% | 11% | 10.7% | 10.6% | 10.2% | 10.5% | 11% | 11.3% | 11.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 95,371 | 95,200 | 1,00,423 | 98,859 | 1,00,475 | 97,188 | 95,735 | 92,852 | 91,791 | 91,387 | 89,249 | 86,972 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Edward Menezes | Shareholding of Promoter and Promoter Group | 29.1% | 1.61 Cr |
| Sunil Srinivasan Chari | Shareholding of Promoter and Promoter Group | 13.2% | 72,89,320 |
| Chari Family Trust In The Name Of Sunil Srinivasan Chari And Jyotishna Sunil Chari | Shareholding of Promoter and Promoter Group | 9.2% | 51,10,000 |
| Uti-flexi Cap Fund | Public Shareholding | 6.4% | 35,22,645 |
| Rossari Biotech (india) Pvt Ltd | Shareholding of Promoter and Promoter Group | 5.5% | 30,16,200 |
| Yash Sunil Chari | Shareholding of Promoter and Promoter Group | 4.5% | 24,65,000 |
| Life Insurance Corporation Of India | Public Shareholding | 4% | 22,19,115 |
| Sbi Small Cap Fund | Public Shareholding | 3.5% | 19,62,239 |
| Canara Robeco Mutual Fund A/c Canara Robeco Small Cap Fund | Public Shareholding | 1.9% | 10,67,293 |
| Anita Menezes | Shareholding of Promoter and Promoter Group | 1.8% | 10,02,630 |
| Motilal Oswal Small Cap Fund | Public Shareholding | 1.6% | 8,55,699 |
| Mikhail Menezes | Shareholding of Promoter and Promoter Group | 0.2% | 1,33,200 |
| Menezes Family Trust In The Name Of Edward Walter Menezes And Anita Menezes | Shareholding of Promoter and Promoter Group | 0.2% | 1,10,000 |
| Rossari Manuchar (india) Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Suisse Silicon Specialties Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Glad Properties (india) Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sunjyot Properties Llp | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Henry Menezes | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Yvette Santhmayor | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Stella Dcunha | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Charlotte Dmello | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Priya Shivdasani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Malini Nainani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Satish Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Chanderkanta Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Edward Menezes | 0 | 0% | 2026-03-31 |
| Sunil Srinivasan Chari | 0 | 0% | 2026-03-31 |
| Yash Sunil Chari | 0 | 0% | 2026-03-31 |
| Anita Menezes | 0 | 0% | 2026-03-31 |
| Mikhail Menezes | 0 | 0% | 2026-03-31 |
| Henry Menezes | 0 | 0% | 2026-03-31 |
| Yvette Santhmayor | 0 | 0% | 2026-03-31 |
| Stella Dcunha | 0 | 0% | 2026-03-31 |
| Charlotte Dmello | 0 | 0% | 2026-03-31 |
| Priya Shivdasani | 0 | 0% | 2026-03-31 |
| Malini Nainani | 0 | 0% | 2026-03-31 |
| Satish Mehta | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Edward Menezes | Chairman/ED & CEO | 2026 |
| Sunil Chari | ED / MD / Promoter | 2026 |
| Aseem Dhru | Independent Non Exe. Director | 2026 |
| Esha Achan | Independent Non Exe. Director | 2026 |
| GURUDAS VISHWAS ARAS | Independent Non Exe. Director | 2026 |
| Udey Paul Singh Gill | Independent Director | 2026 |
| PARUL GUPTA | CS / Compliance Officer / Legal Head | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Specialty chemicals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,220 Cr | 69.7% |
| Outside India | ₹532 Cr | 30.3% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 12 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-10 | Dividend (0.5/- per share) | Final |
| dividend | 2026-07-10 | ₹0.5 (25%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 1,616 | 34 | 0 | 3 | 0 | 1,655 |
| 2026 | 695 | 9 | 0 | 0 | 0 | 704 |
| 2026 | 662 | 24 | 0 | 3 | 0 | 691 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Chari Family Trust - in the name of Sunil Srinivasan Chari & Jyotishna Sunil ChariAcquisition · 50,00,000
Jyotishna Sunil ChariAcquisition · 15,00,000
Yash Suni ChariAcquisition · 23,00,000
Sunil Srinivasan ChariDisposal · 88,00,000
Jose Abraham RevisedPledge · 1,350
Jose AbrahamRevoke · 600
Substantial Acquisitions (SAST)
2 disclosure(s)
NULL28/08/2025 · 88,00,000
Market06/05/2025 · 25,253
Company Information
Incorporated2009
ChairmanEdward Menezes
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
📍 201 A-B 2nd Floor LBS Marg, Akruti Corporate Park Kanjur(W, Mumbai, Maharashtra, 400079
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search